Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 31:14:1390350.
doi: 10.3389/fonc.2024.1390350. eCollection 2024.

Ureter mixed neuroendocrine-non-neuroendocrine neoplasm: a case report and literature review

Affiliations
Case Reports

Ureter mixed neuroendocrine-non-neuroendocrine neoplasm: a case report and literature review

Bing Zhou et al. Front Oncol. .

Abstract

Cases of mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) of the urinary system are rare, and reports of primary MiNENs in the ureter are lacking. Herein, we present the case of a 71-year-old man who presented with painless gross hematuria and weight loss. Contrast-enhanced abdominal computed tomography (CT) revealed a tumor, comprising small cell neuroendocrine carcinoma (SCNEC) and adenocarcinomatous components, attached to the ureter. The SCNEC components were strongly positive for synaptophysin, CD56 and INSM1 and adenocarcinomatous components were strongly positive for CDX2 and cytokeratin 20, respectively. Four weeks post-surgery, the patient received four cycles of cisplatin-based chemotherapy; the 7-month follow-up CT confirmed that he was healthy without disease recurrence. The occurrence of MiNEN in the ureter with SCNEC and adenocarcinomatous components is extremely rare, wherein histopathological and immunohistochemical features aid in the diagnosis MiNEN. With its aggressive nature, MiNEN can only be effectively treated by early diagnosis and radical surgery.

Keywords: MiNEN; diagnosis; immunohistochemistry; mixed neuroendocrine-non-neuroendocrine neoplasm; ureter.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Contrast-enhanced computerized tomography (CECT) of the left ureteral segment and left hydronephrosis. CECT revealed a 20-mm lesion on the left ureteral segment. Neuroendocrine carcinoma and adenocarcinoma in biopsy. Low ((B), hematoxylin-eosin, × 40) and intermediate [(C), hematoxylin-eosin, × 200] magnification showing adenocarcinoma and Neuroendocrine carcinoma. Neuroendocrine in biopsy: High magnification [(D), hematoxylin-eosin, × 400]. Adenocarcinoma in biopsy: High magnification [(E), hematoxylin-eosin, × 400].
Figure 2
Figure 2
Neuroendocrine carcinoma and adenocarcinoma in biopsy. Low [(A), hematoxylin-eosin, × 40]. Immunohistochemical staining showed positivity for a urothelial marker [(GATA3 (B)], neuroendocrine marker [synaptophysin (C)], adenocarcinoma marker [CDX2 (D)], a neuroendocrine marker [CD56 (E)], adenocarcinoma marker [CDX2 (F), epithelial marker (CKpan (G)], a neuroendocrine marker [INSM1 (H)], a neuroendocrine marker [SSTR2 (I)] and proliferation index marker [Ki67 (J)].
Figure 3
Figure 3
A timeline figure summarising the case diagnosis and treatment pathway.

Similar articles

References

    1. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. . The 2019 who classification of tumours of the digestive system. Histopathology. (2020) 76:182–8. doi: 10.1111/his.13975 - DOI - PMC - PubMed
    1. Robinson L, Schouwstra CM, van Heerden WFP. Oropharyngeal mixed neuroendocrine-nonneuroendocrine neoplasm (Minen): A case report and literature review. Head Neck Pathol. (2021) 15:1415–20. doi: 10.1007/s12105-021-01312-w - DOI - PMC - PubMed
    1. Maragliano R, Libera L, Carnevali I, Pensotti V, De Vecchi G, Testa M, et al. . Mixed neuroendocrine/non-neuroendocrine neoplasm (Minen) of the ovary arising from endometriosis: Molecular pathology analysis in support of a pathogenetic paradigm. Endocrine Pathol. (2022) 33:400–10. doi: 10.1007/s12022-021-09689-8 - DOI - PMC - PubMed
    1. Jang H, Yuk SM, Kim JO, Han DS. A rare case of primary Malignant small cell carcinoma combined with urothelial cell carcinoma in the ureter. World J Surg Oncol. (2013) 11:181. doi: 10.1186/1477-7819-11-181 - DOI - PMC - PubMed
    1. Nakasato T, Hiramatsu A, Matsui Y, Unoki T, Shimoyama H, Oshinomi K, et al. . Systematic review and two new cases of primary upper urinary tract neuroendocrine carcinomas. Cancer Treat Res Commun. (2018) 17:23–30. doi: 10.1016/j.ctarc.2018.10.003 - DOI - PubMed

Publication types